Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Wagner

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Bioorganic & Medicinal Chemistry|November 20, 2019
Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virusA Chris Krueger, Hui-Ju Chen, John T Randolph, et al.
Journal of Medicinal Chemistry|January 18, 2018
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral BioavailabilityJohn T Randolph, A Chris Krueger, Pamela L Donner, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novel antibacterial classPeter J Dandliker, Steve D Pratt, Angela M Nilius, et al.
Journal of Medicinal Chemistry|April 15, 2018
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)Rolf Wagner, John T Randolph, Sachin V Patel, et al.
Journal of Medicinal Chemistry|January 10, 2014
Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5ADavid A DeGoey, John T Randolph, Dachun Liu, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Bioorganic & Medicinal Chemistry|November 20, 2019
Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virusA Chris Krueger, Hui-Ju Chen, John T Randolph, et al.
Journal of Medicinal Chemistry|January 18, 2018
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral BioavailabilityJohn T Randolph, A Chris Krueger, Pamela L Donner, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novel antibacterial classPeter J Dandliker, Steve D Pratt, Angela M Nilius, et al.
Journal of Medicinal Chemistry|April 15, 2018
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)Rolf Wagner, John T Randolph, Sachin V Patel, et al.
Journal of Medicinal Chemistry|January 10, 2014
Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5ADavid A DeGoey, John T Randolph, Dachun Liu, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
Pageof 6